Skip to content

THE VALIDITY OF THE AEONOSE IN DISCRIMINATING DYSPNEA RESULTING FROM HEART FAILURE OR FROM PULMONARY ORIGIN

THE VALIDITY OF THE AEONOSE IN DISCRIMINATING DYSPNEA RESULTING FROM HEART FAILURE OR FROM PULMONARY ORIGIN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25949
Enrollment
450
Registered
2015-08-03
Start date
2015-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure (NYHA class II-IV) COPD GOLD class II-IV Enose

Interventions

All participants will be asked to breath 5 minutes through the sampling setup that consists of a non-rebreathing T-valve with an active carbon filter attached to the inlet. During sampling, a nose cla

Sponsors

Diaconessenhuis Meppel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Signed Informed consent • A diagnosis of either heart failure NYHA class II-IV or COPD GOLD severity of obstruction II-IV. • age > 40years

Exclusion criteria

Exclusion criteria: • Artificial cardiac pacemaker • Atrial fibrillation or atrial flutter • Acute medical events in the 6 weeks prior to inclusion (cardiac, pulmonary or otherwise if requiring an intervention) • Patients with cancer • Tracheostoma • Inability to understand the patient information

Design outcomes

Primary

MeasureTime frame
The ability of the Aeonose to discriminate between patients with heart failure (NYHA class II-IV) versus COPD GOLD class II-IV

Secondary

MeasureTime frame
- Time involved in obtaining Aeonose read-out - Technical or patient related problems obtaining a read-out from the Aeonose. - Adverse effects of using the Aeonose

Contacts

Public ContactA. Huisman

Diaconessenhuis Meppel

huismana@noorderboog.nl0522 - 23 33 33

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)